NEOGAP Therapeutics is a Pharmaceutical manufacturing industry.
NEOGAP Therapeutics has raised $9.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2026.
NEOGAP Therapeutics's investors include European Innovation Council, Sciety, Eurostars, 3T Invest, Sciety Venture Partners.
NEOGAP Therapeutics is headquartered in Stockholm, Sweden.
NEOGAP Therapeutics is a Pharmaceutical manufacturing industry.
NEOGAP Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NEOGAP Therapeutics — Funding & Investors." VCBacked, February 11, 2026, https://www.vcbacked.co/company/neogap-therapeutics. Accessed September 29, 2026.
VCBacked. (2026). NEOGAP Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/neogap-therapeutics
{{cite web |title=NEOGAP Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neogap-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated